The EMA has approved Gilenya® (fingolimod) for the treatment of children and adolescents with relapsing–remitting forms of multiple sclerosis.
For the first time in the UK, a team of surgeons have operated on abnormally developed spinal cords of two fetuses with spina bifida.
A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Kijun Yoon, who discussed the latest updates in Zika research, including his work on a Zika virus protein that may cause microcephaly.
NCTalks on neuromodulation in children: an interview with Jean-Pierre Lin, President of the British Paediatric Neurology Association
Dr Lin tells Lauren Pulling (Editor, NC) about his work as a pediatric neurologist, and recent advances in deep brain stimulation for infants.
This Review looks at the literature surrounding recent neurophysiological techniques and novel surgical tools in pediatric epilepsy.
Research suggests increasing synaptic activity could alleviate SMA symptoms: motor function of mice was improved when treated with a glutamate receptor stimulant.
Angelman syndrome and Dup15q syndrome: two rare diseases working together to solve each other’s puzzles – a conversation with Jill Silverman and Nathalie Buscher
In this interview, Drs Silverman and Buscher discuss their work, and how these two rare diseases are shedding light not only on each other, but also a wealth of other neurological disorders.
Researchers have used MRI scans to predict risk of developing autism in infants long before symptoms occur – autism was correctly predicted in 80% of infants.
Serotonin receptor agonist discovered in a zebrafish model decreased seizure frequency in small pediatric clinical trial.